The Carlyle Group Inc. 13D and 13G filings for OnKure Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-10 4:30 pm Purchase | 2024-10-08 | 13D | OnKure Therapeutics, Inc. OKUR | Carlyle Group Inc. CG | 273,045 2.200% | 273,045 (New Position) | Filing |